Imugene Azer-cel CAR-T Trial Featured on 10 News | Patient Story | Imugene Limited
Imugene Azer-cel CAR-T Trial Featured on 10 News | Patient Stor…
9.9K views1 month ago
linkedin.com
Imugene highlights azer-cel progress as trial patient enters remission
Imugene highlights azer-cel progress as trial patient enters re…
1 month ago
YahooProactive
Imugene prepares pivotal azer-cel trial with FDA
Imugene prepares pivotal azer-cel trial with FDA
5 months ago
proactiveinvestors.com.au
Imugene Investor Webinar - FDA Meeting Results | Imugene Limited
Imugene Investor Webinar - FDA Meeting Results | Imugene Limited
9.7K views3 months ago
linkedin.com
Imugene prepares pivotal azer-cel trial with FDA - ICYMI
Imugene prepares pivotal azer-cel trial with FDA - ICYMI
5 months ago
proactiveinvestors.com
Imugene hits 82% response rate in blood cancer trial - ICYMI
Imugene hits 82% response rate in blood cancer trial - ICYMI
4 months ago
proactiveinvestors.com.au
Imugene highlights azer-cel progress as trial patient enters remission
Imugene highlights azer-cel progress as trial patient enters re…
1 month ago
proactiveinvestors.com.au
Lymphoma Survivor Shares His Story: Breakthrough CAR-T Trial | …
9.7K views3 months ago
linkedin.com
FDA backs Imugene’s azer-cel treatment plan - ICYMI
4 months ago
proactiveinvestors.com.au
Leslie Chong on Imugene’s 83% Response Rates Path to FDA Appr…
9.9K views1 month ago
linkedin.com
Imugene secures $2.7m R&D tax refund to support clinical programs
1 month ago
proactiveinvestors.co.uk
Imugene doses first combination patient in lung cancer clinical trial
May 31, 2023
proactiveinvestors.com.au
Imugene has cancer vaccine trial data published in prestigious med…
Feb 25, 2019
proactiveinvestors.com.au
Imugene advances to cohort three of VAXINIA monotherapy dose esc…
Apr 4, 2023
proactiveinvestors.com.au
Imugene to open new PD1-Vaxx Phase 2 bowel cancer clinical trial …
Dec 5, 2023
proactiveinvestors.com.au
Imugene talks VAXINIA MAST trial and corporate ambition
Sep 4, 2023
proactiveinvestors.com.au
Imugene’s $20 million boost and cancer trial updates
Feb 2, 2025
proactiveinvestors.com.au
Imugene doses first patient in Phase 2 clinical trial
2 viewsSep 8, 2022
proactiveinvestors.com.au
Groundbreaking cancer trial: Imugene’s CF33 advances in clini…
Nov 13, 2024
proactiveinvestors.com.au
Imugene doses first patients of VAXINIA MAST combination trial
Mar 2, 2023
proactiveinvestors.com
Imugene achieves ‘complete response’ with mid dose cancer trial
Jan 19, 2024
proactiveinvestors.com
Imugene's CMO John Byon on latest cancer trial data
10 months ago
proactiveinvestors.com.au
Imugene CMO and CEO talk trial momentum and immuno-oncolog…
10 months ago
proactiveinvestors.com.au
Imugene trial: 75% response rate in diffuse large B-cell lymphoma
9 months ago
proactiveinvestors.com.au
Imugene’s Phase 1 onCARlytics clinical trial doses first patient in i…
Feb 14, 2024
proactiveinvestors.com.au
Imugene secures IND approval for first-in-class onCARlytics trial
May 19, 2023
proactiveinvestors.com
Imugene sees positive early signs in VAXINIA trial; “may be potent anti …
Nov 6, 2023
proactiveinvestors.com.au
Imugene doses first patient for VAXINIA bile tract cancer trial in M…
Jul 10, 2024
proactiveinvestors.com.au
Imugene advances Phase 1 MAST trial for cancer-killing VAXINIA virus
Nov 2, 2023
proactiveinvestors.com
Imugene reports promising results in Phase 1b trial for azer-cel in DL…
Sep 2, 2024
proactiveinvestors.com
See more videos
Static thumbnail place holder